Phase 3
Completed N=157
Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo
HC-BPPV
Source: ClinicalTrials.gov NCT00810641 ↗
Enrolled (actual)
157
Serious AEs
—
Results posted
Jun 2011
Primary outcomePrimary: Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial — 38; 33; 17 participants
Summary
The purpose of this study was to compare the immediate efficacies of each treatment maneuvers in treatment of apogeotropic horizontal canal benign paroxysmal positional vertigo (HC-BPPV).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial |
38; 33; 17 | — |
Eligibility Criteria
Inclusion Criteria
- a history of brief episodes of positional vertigo,
- direction-changing horizontal nystagmus beating toward the uppermost (apogeotropic nystagmus) or undermost (geotropic nystagmus) ear in both the lateral head turning positions,
- no spontaneous nystagmus during upright sitting position, and
- absence of identifiable central nervous system disorders that could explain the positional vertigo and nystagmus.
Exclusion Criteria
- central positional nystagmus with identifiable CNS lesions that could explain the positional nystagmus
Data sourced from ClinicalTrials.gov (NCT00810641). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.